Key facts
- Datos Health’s last known valuation is $31.5M.
- It has raised $23.6M; the latest was Later Stage VC ($5.9M) in Jul 2024.
- Notable investors include Industry Ventures, Vertex Ventures Israel, Angular Ventures, Crescendo Venture Partners, Intuition Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Datos Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Datos Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Datos Health
Operator of a remote patient monitoring platform intended to implement and customize automated remote care programs for any clinical workflow. The company's platform helps care teams to fine-tune workflows to their needs and protocols, either by creating remote care programs from scratch or by leveraging existing protocols, enabling patients to manage parts of their care journey themselves and reducing the workload for clinicians.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2015
- Employees
- 50
- Website
- datos-health.com/
- Ownership
- Privately Held (backing)
Datos Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Datos Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Datos Health in its N-PORT filings yet. We sweep new filings monthly.